Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Rhododendron-Derived Drugs Now Made by Bacteria

Kobe University bioengineers improved E. coli yields of orsellinic acid to 202 mg/L, enabling scalable production of pharmacologically active compounds like grifolic acid.

Summary by Phys.org
Bioengineered E. coli bacteria can now produce a group of compounds with anticancer, anti-HIV, antidiabetic and anti-inflammatory activities. The Kobe University achievement is the result of a rational design strategy that yields a platform for the industrial production of drug candidates.

2 Articles

Phys.orgPhys.org
Center

Rhododendron-derived drugs now made by bacteria

Bioengineered E. coli bacteria can now produce a group of compounds with anticancer, anti-HIV, antidiabetic and anti-inflammatory activities. The Kobe University achievement is the result of a rational design strategy that yields a platform for the industrial production of drug candidates.

·United Kingdom
Read Full Article
News MedicalNews Medical
Center

Bioengineered E. coli bacteria can now produce rhododendron-derived drugs

Bioengineered E. coli bacteria can now produce a group of compounds with anticancer, anti-HIV, antidiabetic and anti-inflammatory activities.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

News Medical broke the news in United States on Tuesday, February 17, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Science icon

Science

Kobe icon

Kobe

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal